Author

Akihito Tsuji

OpenAlex ID: A5140215416

Clinical outcomes of modified (m)-FOLFOXIRI plus cetuximab versus bevacizumab by metastasis status in RAS/BRAF wild-type and left-sided metastatic colorectal cancer: The DEEPER trial (JACCRO CC-13)

· Yu Sunakawa, Manabu Shiozawa, et al. · Institutional Repositories DataBase (IRDB)

Final analysis of modified (m)-FOLFOXIRI plus cetuximab versus bevacizumab for RAS wild-type and left-sided metastatic colorectal cancer: The DEEPER trial (JACCRO CC-13).

· Akihito Tsuji, Yu Sunakawa, et al. · Institutional Repositories DataBase (IRDB)

Encorafenib and cetuximab with/without binimetinib therapies for patients with BRAF-mutated metastatic colorectal cancer with prognostic factors: The BEETS trial (JACCRO CC-18).

· Yu Sunakawa, Eisuke Inoue, et al. · Institutional Repositories DataBase (IRDB)

Works count: 3

Citation count:

H-index:

I10-index: